Literature DB >> 35779183

Serum osmolality and hyperosmolar states.

Bahar Büyükkaragöz1, Sevcan A Bakkaloğlu2.   

Abstract

Serum osmolality is the sum of the osmolalities of every single dissolved particle in the blood such as sodium and associated anions, potassium, glucose, and urea. Under normal conditions, serum sodium concentration is the major determinant of serum osmolality. Effective blood osmolality, so-called blood tonicity, is created by the endogenous (e.g., sodium and glucose) and exogenous (e.g., mannitol) solutes that are capable of creating an osmotic gradient across the membranes. In case of change in effective blood osmolality, water shifts from the compartment with low osmolality into the compartment with high osmolarity in order to restore serum osmolality. The difference between measured osmolality and calculated osmolarity forms the osmolal gap. An increase in serum osmolal gap can stem from the presence of solutes that are not included in the osmolarity calculation, such as hypertonic treatments or toxic alcoholic ingestions. In clinical practice, determination of serum osmolality and osmolal gap is important in the diagnosis of disorders related to sodium, glucose and water balance, kidney diseases, and small molecule poisonings. As blood hypertonicity exerts its main effects on the brain cells, neurologic symptoms varying from mild neurologic signs and symptoms to life-threatening outcomes such as convulsions or even death may occur. Therefore, hypertonic states should be promptly diagnosed and cautiously managed. In this review, the causes and treatment strategies of hyperosmolar conditions including hypernatremia, diabetic ketoacidosis, hyperglycemic hyperosmolar syndrome, hypertonic treatments, or intoxications are discussed in detail to increase awareness of this important topic with significant clinical consequences.
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Entities:  

Keywords:  Blood tonicity; Children; Hyperosmolar states; Osmolal gap; Serum osmolality; Serum osmolarity

Year:  2022        PMID: 35779183     DOI: 10.1007/s00467-022-05668-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  45 in total

Review 1.  Hyperosmolar states.

Authors:  R A Star
Journal:  Am J Med Sci       Date:  1990-12       Impact factor: 2.378

Review 2.  The serum osmole gap.

Authors:  J A Kruse; P Cadnapaphornchai
Journal:  J Crit Care       Date:  1994-09       Impact factor: 3.425

3.  Gaps--anionic and osmolal.

Authors:  N Smithline; K D Gardner
Journal:  JAMA       Date:  1976-10-04       Impact factor: 56.272

4.  Osmolal gap in hemodialyzed uremic patients.

Authors:  Ioannis Griveas; Athina Gompou; Ilias Kyritsis; Georgios Papatheodorou; Ioannis Agroyannis; Manolis Tsakoniatis; Evaggelos Kapeleris; Sotiris Vrachnes
Journal:  Artif Organs       Date:  2011-08-16       Impact factor: 3.094

5.  Evaluation of 36 formulas for calculating plasma osmolality.

Authors:  Andreas S Fazekas; Georg-Christian Funk; Daniela S Klobassa; Horst Rüther; Ingrid Ziegler; Rolf Zander; Hans-Jürgen Semmelrock
Journal:  Intensive Care Med       Date:  2012-10-19       Impact factor: 17.440

Review 6.  Body fluid dynamics: back to the future.

Authors:  Gautam Bhave; Eric G Neilson
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

Review 7.  Current concepts. Serum osmolality. Uses and limitations.

Authors:  F J Gennari
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

Review 8.  Diagnosis and Management of Disorders of Body Tonicity-Hyponatremia and Hypernatremia: Core Curriculum 2020.

Authors:  N Winn Seay; Ruediger W Lehrich; Arthur Greenberg
Journal:  Am J Kidney Dis       Date:  2019-10-10       Impact factor: 8.860

Review 9.  Toxic alcohol ingestions: clinical features, diagnosis, and management.

Authors:  Jeffrey A Kraut; Ira Kurtz
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 8.237

Review 10.  Hypertonicity: Clinical entities, manifestations and treatment.

Authors:  Helbert Rondon-Berrios; Christos Argyropoulos; Todd S Ing; Dominic S Raj; Deepak Malhotra; Emmanuel I Agaba; Mark Rohrscheib; Zeid J Khitan; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2017-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.